RSD-921
RSD-921 (PD-123497) is a potent Na+ channel blocker with anti-arrhythmic activity. RSD-921 displays a low affinity for κ-opioid receptors and behaves as a weak κ-agonist in vitro. RSD 921 displays state-, time- and voltage-dependent block of the open state of cardiac, skeletal muscle and neuronal Na+ channels expressed in Xenopus oocytes. RSD-921 can be used for cardiac arrhythmias research[1][2].
Product Specifications
CAS Number
114419-77-1
Product Name Alternative
PD-123497
UNSPSC
12352005
Target
Opioid Receptor; Sodium Channel
Related Pathways
GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Cardiovascular Disease
Smiles
O=C(N(C)[C@H]1[C@H](N2CCCC2)CCCC1)CC3=C(C=CS4)C4=CC=C3
Molecular Formula
C21H28N2OS
Molecular Weight
356.52
References & Citations
[1]Meecham KG, et al. An in vitro profile of activity for the (+) and (-) enantiomers of spiradoline and PD117302. Eur J Pharmacol. 1989 Dec 7;173 (2-3) :151-7.|[2]Pugsley MK, et al. Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921. Br J Pharmacol. 1999 May;127 (1) :9-18.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15363841 1 Vial
Lentiviral human MMD2 sgRNA gene knockout kit - Lentiviral human MMD2 sgRNA gene knockout kit (100)
Sign In for Pricing
View Details MBS7018619-01 0.02 mg
Recombinant Prolipoprotein diacylglyceryl transferase (lgt)
Sign In for Pricing
View Details MBS7018619-02 0.1 mg
Recombinant Prolipoprotein diacylglyceryl transferase (lgt)
Sign In for Pricing
View Details MBS7018619-03 5x 0.1 mg
Recombinant Prolipoprotein diacylglyceryl transferase (lgt)
Sign In for Pricing
View Details 